It is a pharma private limited company based in Chennai 600083, Tamil Nadu, India, established in 2005.
2005 | Chennai 600083, Tamil Nadu, India | ActiveDuncan Pharma Private Limited, a active private limited company, was established on 18 May 2005 in Chennai 600083, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24231TN2005PTC056343. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹0.30 M.
It upholds a active non-compliant status. Its leadership includes Varadarajan Dhivyalakshmi (Director), Ida Ebenezar (Director). Past directors included Kalathi Vadivelu Murugan, Muthiah Varadarajan Dhanalakshmi, Hemalatha Varadarajan. It holds ₹1.22 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Old No.9, New No.1218Th Avenue Ashok Nagar, Chennai 600083, Tamil Nadu, 600083.
U24231TN2005PTC056343
056343
18 May 2005
₹3.00 M
₹0.30 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Duncan Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varadarajan Dhivyalakshmi | Director | 20 Apr 2020 | Current |
| Ida Ebenezar | Director | 20 Apr 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Oct 2009 | Past |
| Pramod Abcsdd | Director | 08 Jul 2020 | Past |
| Pramod Abcsdd | Director | 08 Jul 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Duncan Pharma Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 1.12% decrease. The company also saw a substantial improvement in profitability, with a 13.94% increase in profit. The company's net worth observed a substantial decline by a decrease of 41.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Duncan Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,160,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2010 | Through Dy. Director Of Industries Single Window Clearance Agency | ₹0.66 M | Open |
| 23 Jun 2006 | Karur Vysya Bank Limited | ₹4.00 M | Open |
| 23 Jun 2006 | Karur Vysya Bank Ltd. | ₹7.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Duncan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Duncan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Duncan Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Duncan Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Duncan Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
The activity Varadarajan Dhivyalakshmi was appointed as a Director was appointed as a Director on 20 Apr 2020 & has been associated with this company since 5 years 8 months . was completed.
Ida Ebenezar was appointed as a Director was appointed as a Director on 20 Apr 2020 & has been associated with this company since 5 years 8 months . was recorded as a recent event.
The activity A charge with Karur Vysya Bank Limited of Rs. 4.00 M registered on 23 Jun 2006 with Charge ID 80025310 was modified on 15 Jul 2013. was completed.
A charge with Through Dy. Director Of Industries Single Window Clearance Agency amounted to Rs. 0.66 M with Charge ID 10251783 was registered on 24 Nov 2010. was recorded as a recent event.
The CIN of Duncan Pharma Private Limited is U24231TN2005PTC056343.
Duncan Pharma Private Limited is headquartered at Old No.9, New No.1218Th Avenue Ashok Nagar, Chennai 600083, Tamil Nadu, 600083.
Duncan Pharma Private Limited was incorporated on 18 May 2005.
The current directors of Duncan Pharma Private Limited are
The primary industry of Duncan Pharma Private Limited is Pharma.
Duncan Pharma Private Limited is unlisted.
The authorized capital of Duncan Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹0.30 M.
The compliance status of Duncan Pharma Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX